Impact of PAP therapy on hospitalization rates in Medicare beneficiaries with COPD and coexisting OSA
- PMID: 29931497
- PMCID: PMC6309578
- DOI: 10.1007/s11325-018-1680-0
Impact of PAP therapy on hospitalization rates in Medicare beneficiaries with COPD and coexisting OSA
Abstract
Objective: Growing evidence supports that patients with chronic obstructive pulmonary disease (COPD) and coexisting obstructive sleep apnea (OSA) have poor prognosis. This association is described as overlap syndrome. Positive airway pressure (PAP) therapy is now the preferred treatment for OSA. We hypothesized that use of PAP therapy in elderly patients with overlap syndrome would be associated with lower healthcare utilization.
Methods: In this retrospective cohort study, we analyzed data from 5% national sample of fee-for-service Medicare beneficiaries with a diagnosis of COPD who were newly started on PAP therapy in 2011. We examined the effect of PAP therapy on emergency room (ER) visits and hospitalizations for all-cause and COPD-related conditions in the 1 year pre- and 1 year post-initiation of PAP therapy.
Results: In year 2011, we identified 319 patients with overlap syndrome who were new users of PAP therapy. In this cohort of patients, hospitalization rates for COPD-related conditions were significantly lower in the 1 year post-initiation of PAP therapy compared to the 1-year pre-initiation period (19.4 vs 25.4%, P value = 0.03). However, ER visits (for any cause or COPD-related conditions) and hospitalization rates for any cause did not differ significantly in the pre- and post-initiation periods. PAP therapy was more beneficial in older adults, those with higher COPD complexity, and those with three or more comorbidities.
Conclusion: Initiation of PAP therapy in elderly patients with overlap syndrome is associated with a reduction in hospitalization for COPD-related conditions, but not for all-cause hospitalizations and ER visits.
Keywords: COPD; Hospitalization and healthcare utilization; OSA; Overlap syndrome; PAP.
Conflict of interest statement
Figures


Similar articles
-
Impact of Positive Airway Pressure Therapy Adherence on Outcomes in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease.Am J Respir Crit Care Med. 2022 Jul 15;206(2):197-205. doi: 10.1164/rccm.202109-2035OC. Am J Respir Crit Care Med. 2022. PMID: 35436176 Free PMC article.
-
Early recognition of obstructive sleep apnea in patients hospitalized with COPD exacerbation is associated with reduced readmission.Hosp Pract (1995). 2016;44(1):41-7. doi: 10.1080/21548331.2016.1134268. Epub 2016 Jan 20. Hosp Pract (1995). 2016. PMID: 26691510
-
Obstructive Lung Disease and Obstructive Sleep Apnea (OLDOSA) cohort study: 10-year assessment.J Clin Sleep Med. 2020 Feb 15;16(2):267-277. doi: 10.5664/jcsm.8180. Epub 2020 Jan 13. J Clin Sleep Med. 2020. PMID: 31992433 Free PMC article.
-
Sleep disordered breathing: OSA-COPD overlap.Expert Rev Respir Med. 2024 Jun;18(6):369-379. doi: 10.1080/17476348.2024.2373790. Epub 2024 Jul 2. Expert Rev Respir Med. 2024. PMID: 38932721 Review.
-
The use of continuous positive airway pressure in COPD-OSA overlap syndrome: A systematic review.Sleep Med. 2023 Aug;108:55-60. doi: 10.1016/j.sleep.2023.05.025. Epub 2023 Jun 8. Sleep Med. 2023. PMID: 37336060
Cited by
-
Acceptance of and adherence with long-term positive airway pressure treatment in adults with chronic obstructive pulmonary disease: A systematic review protocol.PLoS One. 2023 Jul 3;18(7):e0287887. doi: 10.1371/journal.pone.0287887. eCollection 2023. PLoS One. 2023. PMID: 37399211 Free PMC article.
-
Obstructive Sleep Apnea with Chronic Obstructive Pulmonary Disease among Medicare Beneficiaries.Ann Am Thorac Soc. 2019 Jan;16(1):153-156. doi: 10.1513/AnnalsATS.201712-932OC. Ann Am Thorac Soc. 2019. PMID: 30592457 Free PMC article. No abstract available.
-
Impact of Positive Airway Pressure Therapy Adherence on Outcomes in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease.Am J Respir Crit Care Med. 2022 Jul 15;206(2):197-205. doi: 10.1164/rccm.202109-2035OC. Am J Respir Crit Care Med. 2022. PMID: 35436176 Free PMC article.
-
Review of the prevalence, pathogenesis and management of OSA-COPD overlap.Sleep Breath. 2022 Dec;26(4):1551-1560. doi: 10.1007/s11325-021-02540-8. Epub 2022 Jan 16. Sleep Breath. 2022. PMID: 35034250 Review.
-
Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs.Respir Res. 2023 Mar 25;24(1):93. doi: 10.1186/s12931-023-02401-w. Respir Res. 2023. PMID: 36964552 Free PMC article.
References
-
- Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. The Lancet. 2011;378(9795):991–996. - PubMed
-
- Owens RL, Macrea MM, Teodorescu M. The overlaps of asthma or COPD with OSA: A focused review. Respirology. 2017;22(6):1073–1083. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials